Dr. Kumthekar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
675 N Saint Clair St
Ste 20-100
Chicago, IL 60611Phone+1 312-695-4360Fax+1 312-695-1435
Education & Training
- McGaw Medical Center of Northwestern UniversityResidency, Neurology, 2008 - 2011
- McGaw Medical Center of Northwestern UniversityInternship, Internal Medicine, 2007 - 2008
- Northeast Ohio Medical UniversityClass of 2007
Certifications & Licensure
- FL State Medical License 2024 - Present
- IL State Medical License 2011 - 2026
- American Board of Psychiatry and Neurology Neurology
Clinical Trials
- Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade Glioma
- Bevacizumab in Treating Patients With Recurrent or Progressive Meningiomas Start of enrollment: 2010 Jun 17
- Bevacizumab With or Without Anti-Endoglin Monoclonal Antibody TRC105 in Treating Patients With Recurrent Glioblastoma Multiforme Start of enrollment: 2012 Nov 01
- Join now to see all
Publications & Presentations
PubMed
- Longitudinal CSF Tumor Cell Enumeration and Mutational Analysis as a Driver for Leptomeningeal Disease Management.Arushi Tripathy, Pericles Corkos, Barbara Blouw, Deondra A Montgomery, Melissa Moore
Cancers. 2025-02-27 - 1 citationsNANO-LM: An updated scorecard for the clinical assessment of patients with leptomeningeal metastases.Emilie Le Rhun, Lakshmi Nayak, Mary Jane Lim-Fat, Roberta Rudà, Elena Pentsova
Neuro-Oncology. 2025-02-10 - 1 citationsClinical outcomes for pleomorphic xanthoastrocytoma patients.Jared J Sullivan, James P Chandler, Maciej S Lesniak, Matthew C Tate, Adam M Sonabend
Neuro-Oncology Practice. 2025-02-01
Lectures
- A phase 0 first-in-human study using NU-0129: A gold base spherical nucleic acid (SNA) nanoconjugate targeting BCL2L12 in recurrent glioblastoma patients.2019 ASCO Annual Meeting - 6/1/2019
- A phase II trial of bevacizumab in patients with recurrent solid tumor brain metastases who have failed whole brain radiation therapy (WBRT).2019 ASCO Annual Meeting - 6/1/2019
Press Mentions
- Combination Therapy Does Not Extend Survival in GlioblastomaNovember 20th, 2024
- Moleculin Announces First Patients Treated in Phase 2 Clinical Trial of STAT3 Inhibitor in Combination with Radiation for the Treatment of GlioblastomaSeptember 9th, 2024
- Biocept to Host Key Opinion Leader Webinar on October 14 to Discuss Its Proprietary CNSide™ Assay to Detect and Quantify Cancer That Metastasized to the Central Nervous SystemOctober 6th, 2022
- Join now to see all
Grant Support
- A Phase II Clinical Trial in Newly Diagnosed Glioblastoma Patients Treated with WP1066 and RadiationNORTHWESTERN UNIVERSITY AT CHICAGO2023–2028
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: